Dr. Gilmore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2216 W. Thomas St.
Chicago, IL 60622Phone+1 312-770-2272Fax+1 312-770-8535
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Baylor College of MedicineResidency, Internal Medicine, 2014 - 2017
Rush Medical College of Rush University Medical CenterClass of 2014
Certifications & Licensure
IL State Medical License 2017 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 17 citationsNeutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) T...Nicole K. Yun, Sherin J. Rouhani, Christine M. Bestvina, Ethan M. Ritz, Brendan A. Gilmore
Cancers. 2021-03-20 - 7 citationsWhen Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.Brendan A. Gilmore, Roger A. Rodby, David Cimbaluk, Parameswaran Venugopal, Pritesh R. Patel
Clinical Lymphoma, Myeloma & Leukemia. 2019-06-01
Press Mentions
A Small-Molecular Inhibitor Against Proteus Mirabilis Urease to Treat Catheter-Associated Urinary Tract InfectionsFebruary 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
